AcrIIA7 hijacks tracrRNA to block CRISPR-Cas system

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• The CRISPR-Cas9 system is a powerful gene-editing tool relying on a ribonucleoprotein (RNP) complex.
• Anti-CRISPR proteins (Acrs) are known inhibitors of CRISPR-Cas systems, but their mechanisms are not fully understood.
• AcrIIA7's inhibitory mechanism against Cas9 was previously unclear.

Purpose of the Study:

• To elucidate the inhibitory mechanism of the anti-CRISPR protein AcrIIA7 against the CRISPR-Cas9 system.
• To determine the structural basis for AcrIIA7's interaction with Cas9 components.
• To identify novel strategies for CRISPR-Cas system inhibition.

Main Methods:

• X-ray crystallography to determine the structure of AcrIIA7.
• Biochemical assays to analyze the interaction between AcrIIA7, Cas9, crRNA, and tracrRNA.
• Structural analysis to understand the binding interface and mechanism of inhibition.

Main Results:

• The structure of AcrIIA7 was determined, revealing its unique inhibitory mechanism.
• AcrIIA7 specifically binds to the trans-activating CRISPR RNA (tracrRNA).
• This binding prevents the association of tracrRNA with CRISPR-derived RNA (crRNA), inhibiting the formation of the active Cas9 RNP complex.

Conclusions:

• AcrIIA7 employs a novel 'tracrRNA hijacking' mechanism to inhibit CRISPR-Cas9.
• This study provides the first structural insights into tracrRNA-targeted anti-CRISPR activity.
• RNA-RNA interaction interfaces are identified as critical targets for modulating CRISPR-Cas immunity.